874760

Astellas Pharma Inc. — FEI 3002807001

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 11, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Takaoka (Japan)

Citations

IDCFRDescription
117421 CFR 211.42(b)Product flow through building is inadequate
145121 CFR 211.113(b)Procedures for sterile drug products
354721 CFR 211.46(b)Equipment for Environmental Control
358521 CFR 211.110(a)Control procedures to monitor and validate performance
440221 CFR 211.192Written record of investigation incomplete